Uncategorized

post thumbnail

First Quantum Minerals Limited Now Covered by Analysts at Sanford C. Bernstein (FM)

Sanford C. Bernstein began coverage on shares of First Quantum Minerals Limited (TSE:FM) in a research note issued on Tuesday. The firm set an “outperform” rating and a C$23.75 price target on the stock. Sanford C. Bernstein’s price objective indicates a potential upside of 38.89% from the stock’s previous close. Several other analysts have also […]
post thumbnail

Veresen Coverage Initiated at Canaccord Genuity (VSN)

Investment analysts at Canaccord Genuity initiated coverage on shares of Veresen (TSE:VSN) in a note issued to investors on Tuesday. The firm set a “hold” rating and a C$17.50 price target on the stock. Canaccord Genuity’s price objective points to a potential downside of 5.51% from the company’s current price. Shares of Veresen (TSE:VSN) traded […]
post thumbnail

Tallgrass Energy Partners Receives Buy Rating from Citigroup Inc. (TEP)

Tallgrass Energy Partners (NYSE:TEP)‘s stock had its “buy” rating reaffirmed by stock analysts at Citigroup Inc. in a report issued on Tuesday. They currently have a $57.50 price objective on the stock. Citigroup Inc.’s target price indicates a potential upside of 15.00% from the stock’s previous close. Shares of Tallgrass Energy Partners (NYSE:TEP) traded up […]
post thumbnail

NGL Energy Partners PT Raised to $33.00 at Barclays (NGL)

Stock analysts at Barclays hoisted their target price on shares of NGL Energy Partners (NYSE:NGL) from $31.00 to $33.00 in a report issued on Tuesday. The firm currently has an “equal weight” rating on the stock. Barclays’ target price would indicate a potential upside of 7.67% from the stock’s previous close. A number of other […]
post thumbnail

Plantronics Price Target Increased to $61.00 by Analysts at Northland Securities (PLT)

Stock analysts at Northland Securities boosted their price target on shares of Plantronics (NYSE:PLT) from $57.00 to $61.00 in a report issued on Tuesday. The firm currently has a “buy” rating on the stock. Northland Securities’ price objective points to a potential upside of 9.24% from the stock’s previous close. In other Plantronics news, insider […]
post thumbnail

Alamos Gold Coverage Initiated at Citigroup Inc. (AGI)

Investment analysts at Citigroup Inc. assumed coverage on shares of Alamos Gold (NYSE:AGI) in a note issued to investors on Tuesday. The firm set a “neutral” rating on the stock. Shares of Alamos Gold (NYSE:AGI) traded up 3.45% during mid-day trading on Tuesday, hitting $6.60. The stock had a trading volume of 522,104 shares. Alamos […]
post thumbnail

Equinix Downgraded by Citigroup Inc. to “Neutral” (EQIX)

Equinix (NASDAQ:EQIX) was downgraded by Citigroup Inc. from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $276.00 price objective on the stock. Citigroup Inc.’s price objective points to a potential upside of 2.17% from the company’s current price. The analysts wrote, “We believe […]
post thumbnail

Paypoint plc Receives Hold Rating from Numis Securities Ltd (PAY)

Paypoint plc (LON:PAY)‘s stock had its “hold” rating reiterated by equities research analysts at Numis Securities Ltd in a research note issued to investors on Tuesday. They currently have a GBX 895 ($13.69) target price on the stock, up from their previous target price of GBX 825 ($12.61). Numis Securities Ltd’s target price indicates a […]
post thumbnail

Oxford Instruments plc’s “Add” Rating Reaffirmed at Numis Securities Ltd (OXIG)

Oxford Instruments plc (LON:OXIG)‘s stock had its “add” rating restated by Numis Securities Ltd in a research note issued on Tuesday. They currently have a GBX 1,200 ($18.35) price target on the stock, up from their previous price target of GBX 1,150 ($17.58). Numis Securities Ltd’s price objective points to a potential upside of 12.78% […]
post thumbnail

Palo Alto Networks Now Covered by Analysts at Guggenheim (PANW)

Stock analysts at Guggenheim assumed coverage on shares of Palo Alto Networks (NASDAQ:PANW) in a report issued on Monday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $200.00 price target on the network technology company’s stock. Guggenheim’s price target points to a potential upside of 17.30% from the stock’s previous close. Palo Alto […]
post thumbnail

Houghton Mifflin Harcourt Coverage Initiated at Oppenheimer (HMHC)

Equities researchers at Oppenheimer began coverage on shares of Houghton Mifflin Harcourt (NASDAQ:HMHC) in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $33.00 price target on the stock. Oppenheimer’s price target would indicate a potential upside of 24.06% from the stock’s previous close. The analysts noted that […]
post thumbnail

TTM Technologies Price Target Increased to $12.00 by Analysts at Canaccord Genuity (TTMI)

Investment analysts at Canaccord Genuity boosted their price objective on shares of TTM Technologies (NASDAQ:TTMI) from $11.00 to $12.00 in a note issued to investors on Monday. The firm currently has a “buy” rating on the stock. Canaccord Genuity’s price objective suggests a potential upside of 19.17% from the stock’s previous close. Other equities research […]
post thumbnail

Celldex Therapeutics Receives “Buy” Rating from WBB Securities (CLDX)

Celldex Therapeutics (NASDAQ:CLDX)‘s stock had its “buy” rating restated by research analysts at WBB Securities in a report released on Monday. They currently have a $40.00 target price on the biopharmaceutical company’s stock, up from their previous target price of $30.00. WBB Securities’ price objective suggests a potential upside of 40.35% from the company’s current […]
post thumbnail

LinkedIn Corp Given Buy Rating at RBC Capital (LNKD)

LinkedIn Corp (NYSE:LNKD)‘s stock had its “buy” rating reiterated by analysts at RBC Capital in a research report issued to clients and investors on Monday. They currently have a $275.00 price target on the social networking company’s stock. RBC Capital’s price target indicates a potential upside of 34.27% from the company’s current price. Shares of […]
post thumbnail

Halozyme Therapeutics Earns Buy Rating from MLV & Co. (HALO)

Halozyme Therapeutics (NASDAQ:HALO)‘s stock had its “buy” rating restated by equities research analysts at MLV & Co. in a research note issued to investors on Monday. They currently have a $20.00 price objective on the biopharmaceutical company’s stock. MLV & Co.’s price target indicates a potential upside of 11.17% from the company’s current price. HALO […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.